ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
33 announcements with these filters
Fredun Pharmaceuticals reported FY26 revenue of ₹639.12 Crore, marking a 40% YoY jump. EBITDA surged 72% while PAT rose ~60% to ₹33.21 Crore.
Fredun Pharmaceuticals Ltd reported revenue from operations of ₹210.4 Cr (+27.2% YoY) and net profit of ₹10.8 Cr (+80.0% YoY) for Q4 FY26.
Fredun Pharmaceuticals approved FY2026 audited financial results and recommended a 7% final dividend. The board also proposed a 2:1 bonus share issue and increased authorized capital.